NASDAQ · Biotechnology

UTHR (UTHR) Stock

$512.70 +0.45% NASDAQ: UTHR Healthcare

Valuation

MetricValue
Price$512.70
Market Cap$21.76B
P/E Ratio20.34
P/B Ratio3.93
P/S Ratio7.36
EPS (TTM)$27.86
52-Week High$609.35
52-Week Low$272.12
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE20.26%
ROA12.62%
ROCE21.38%
Gross Margin86.58%
Operating Margin45.34%
Net Margin40.61%
Debt/Equity0.00
Current Ratio6.60

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.7B$1.9B$2.3B$2.9B$3.2B
Operating Profit$556.0M$980.0M$1.2B$1.4B$1.5B
Net Profit$476.0M$727.0M$985.0M$1.2B$1.3B
EPS$10.06$15.00$19.81$24.64$27.86
Op Margin33.0%50.6%50.9%47.9%47.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$5.2B$6.0B$7.2B$7.4B$7.9B
Total Liabilities$1.2B$1.2B$1.2B$920.0M$784.0M
Cash$895.0M$961.0M$1.2B$1.7B$1.6B
Borrowings$800.0M$800.0M$700.0M$300.0M$0

Latest News

Liquidia (LQDA) Expands YUTREPIA As Patent Case Turns More Favorable Simply Wall St. · Jul 15, 2026 United Therapeutics Insider Sold Shares Worth $5,091,949, According to a Recent SEC Filing MT Newswires · Jul 14, 2026 United Therapeutics Insider Sold Shares Worth $5,173,660, According to a Recent SEC Filing MT Newswires · Jul 13, 2026 United Therapeutics (UTHR) Stock Looks Cheap On Fair Value Despite Strong Returns Simply Wall St. · Jul 12, 2026 BETA Technologies (BETA), Multistate Collaborative Complete Inaugural eVTOL Integration Pilot Program Flights Insider Monkey · Jul 12, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$598.0M$803.0M$978.0M$1.3B$1.6B
Investing Cash Flow$-608.0M$-950.0M$-950.0M$171.0M$-1.1B
Financing Cash Flow$45.0M$75.0M$88.0M$-855.0M$-1.0B
Net Cash Flow$156.0M$66.0M$247.0M$490.0M$-140.0M
Free Cash Flow$477.0M$664.0M$748.0M$1.1B$1.0B

Valuation & Return Ratios

MetricValue
PEG Ratio2.24
EV / EBITDA13.58
FCF Yield4.36%
Quick Ratio4.50
Interest Coverage75.85
Return 1Y67.77%
Return 3Y124.57%
Return 5Y144.78%

Ownership

Insiders Held2.05%
Institutions Held101.92%
Institutions Float Held104.05%
Institutional HolderSharesReport Date
Blackrock Inc.5,399,6492026-03-31
Avoro Capital Advisors LLC2,630,0002026-03-31
Wellington Management Group, LLP2,264,2472026-03-31
Vanguard Portfolio Management LLC2,003,7422026-03-31
Vanguard Capital Management LLC1,957,5392026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIIB $216.04 -0.28% 38.92 $31.92B 0.00%
DGX $236.22 -1.70% 21.70 $26.07B 1.68%
GMABGenmab A/S $29.00 -2.62% 21.45 $17.80B 0.00%
ILMN $207.13 -3.04% 41.56 $31.34B 0.00%
INCY $125.01 +1.45% 15.30 $25.34B 0.00%

About UTHR

UTHR is led by CEO Martine A. Rothblatt, employs 1,305 people, headquartered in Silver Spring, US, publicly traded since 1999.

UTHR stock trades at $512.70 with a market capitalization of $21.76B. The stock is valued at a price-to-earnings (P/E) ratio of 20.34, price-to-book of 3.93, price-to-sales of 7.36. Over the past 52 weeks the stock has ranged between $272.12 and $609.35, and currently trades 15.9% below its 52-week high.

On profitability, UTHR generates a return on equity (ROE) of 20.26% — well above the market average, a sign of a high-quality business, return on capital employed of 21.38%, an operating margin of 45.34%, a net profit margin of 40.61%.

In its most recent fiscal year, UTHR reported annual revenue of $3.2B, net profit of $1.3B, revenue has compounded at 16.5% a year over the last five years, profit at 21.0% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.00 — a conservative balance sheet with little leverage risk, a current ratio of 6.60, total assets of $7.9B, $1.6B in cash and equivalents.

UTHR has an average daily trading volume of 482,604 shares, a beta of 0.57 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides